High mannose-binding lectin serum levels are associated with diabetic retinopathy in Chinese patients with type 2 diabetes

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Huang, Qian ^a   Shang, Guilian ^b   Deng, Haohua ^a   Liu, Jie ^a   Mei, Yan ^c   Xu, Yancheng ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Wuhan University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; INSULIN; MANNOSE BINDING LECTIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CHINESE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANNOSE BINDING LECTIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VISION THREATENING DIABETIC RETINOPATHY; VISUAL DISORDER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; ETHNOLOGY; GENE EXPRESSION; GENETICS; MIDDLE AGED; STATISTICAL MODEL;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENE EXPRESSION; HUMANS; LOGISTIC MODELS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; ROC CURVE;

EID: 84941005080     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130665     Document Type: Article

References (42)

1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. New England Journal of Medicine. 2010; 362: 1090-1101. doi: 10.1056/NEJMoa0908292 PMID: 20335585
2. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007; 14: 179-183. PMID: 17896294
3. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes care. 2012; 35:556-564. doi: 10.2337/dc11-1909 PMID: 22301125
4. Liu Z, Fu C, Wang W, Xu B. Rersearch prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross sectional hospital based survey in urban China. Health Qual Life Outcomes. 2010; 8: 62. doi: 10.1186/1477-7525-8-62 PMID: 20579389
5. Kramer CK, Rodrigues TC, Canani LH, Gross JL, Azevedo MJ. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes meta-analysis of observational studies. Diabetes Care. 2011; 34: 1238-1244. doi: 10.2337/dc11-0079 PMID: 21525504
6. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Diabetic retinopathy. Diabetes Care. 2003; 26:S99-S102. PMID: 12502630
7. Chang WC, White MR, Moyo P, McClear S, Thiel S, Hartshorn KL, et al. Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection. BMC immunology. 2010; 11: 64. doi: 10.1186/1471-2172-11-64 PMID: 21182784
8. Keller TT, van Leuven SI, Meuwese MC, Wareham NJ, Luben R, Stroes ES, et al. Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol. 2006; 26:2345-2350. PMID: 16902159
9. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunology today. 1996; 17: 532-540. PMID: 8961631
10. Bay JT, Sørensen SS, Hansen JM, Madsen HO, Garred P. Low mannose-binding lectin serum levels are associated with reduced kidney graft survival. Kidney international. 2012; 83: 264-271. doi: 10.1038/ki.2012.373 PMID: 23172101
11. Eisen D P, Minchinton R M. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clinical Infectious Diseases. 2003; 37: 1496-1505. PMID: 14614673
12. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab.2003; 88:1082-1088. PMID: 12629088
13. Özkan H, Köksal N, Cetinkaya M, Kiliç Ş, Çelebi S, Oral B, et al. Serum mannose-binding lectin (MBL) gene polymorphism and low MBL levels are associated with neonatal sepsis and pneumonia. Journal of Perinatology. 2011; 32: 210-217. doi: 10.1038/jp.2011.79 PMID: 21681178
14. Ezekowitz RA. Genetic heterogeneity of mannose-binding proteins: the Jekyll and Hyde of innate immunity? Am J Hum Genet. 1998; 62:6-9. PMID: 9443889
15. Hansen TK, Tarnow L, Thiel S, Steffensen R, Stehouwer CD, Schalkwijk CG, et al. Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes. 2004; 53:1570-1576. PMID: 15161763
16. Wang ZY, Sun ZR, Zhang LM. The relationship between serum mannose-binding lectin levels and acute ischemic stroke risk. Neurochem Res. 2014; 39: 248-253. doi: 10.1007/s11064-013-1214-x PMID: 24309995
17. Zhang ZG, Wang C, Wang J, Zhang Z, Yang YL, Gao L, et al. Prognostic Value of Mannose-Binding Lectin: 90-Day Outcome in Patients with Acute Ischemic Stroke. Mol Neurobiol. 2015; 51:230-239. doi: 10.1007/s12035-014-8682-0 PMID: 24691546
18. Siezenga MA, Shaw PK, Daha MR, Rabelink TJ, Berger SP. Low Mannose-Binding Lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic South Asians. A prospective cohort study. Cardiovasc Diabetol. 2011; 10:60. doi: 10.1186/1475-2840-10-60 PMID: 21729275
19. Elawa G, AoudAllah AM, Hasaneen AE, El-Hammady AM. The predictive value of serum mannan-binding lectin levels for diabetic control and renal complications in type 2 diabetic patients. Saudi Med J. 2011; 32:784-790. PMID: 21858386
20. Bouwman LH, Eerligh P, Terpstra OT, Daha MR, de Knijff P, Ballieux BE, et al. Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles. Diabetes. 2005; 54: 3002-3006. PMID: 16186405
21. Hansen TK, Thiel S, Knudsen ST, Gravholt CH, Christiansen JS, Mogensen CE, et al. Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J Clin Endocrinol Metab. 2003; 88: 4857-4861. PMID: 14557465
22. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification: ETDRS report number 10: Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991; 98:S786-S806.
23. AmericanDiabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33:S62-S69. doi: 10.2337/dc10-S062 PMID: 20042775
24. Turner MW. The role of mannose-binding lectin in health and disease. Molecular immunology. 2003; 40: 423-429. PMID: 14568388
25. Koch A, Melbye M, Sørensen P, Homøe P, Madsen HO, Mølbak K, et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA. 2001; 285: 1316-1321. PMID: 11255386
26. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clinical Infectious Diseases. 2003; 37: 1496-1505. PMID: 14614673
27. Walsh MC, Bourcier T, Takahashi K, Shi L, Busche MN, Rother RP, et al. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. The Journal of Immunology. 2005; 175: 541-546. PMID: 15972690
28. Acosta J, Hettinga J, Fluckiger R, Krumrei N, Goldfine A, Angarita L, et al. Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci U S A 2000; 97:5450-5455. PMID: 10805801
29. Hsu SI, Couser WG. Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: a therapeutic role for complement inhibitors? J Am Soc Nephrol. 2003; 14:S186-S191. PMID: 12819326
30. Vang Petersen S, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Molecular immunology. 2001; 38: 133-149. PMID: 11532276
31. Pavlov VI, La Bonte LR, Baldwin WM, Markiewski MM, Lambris JD, Stahl GL. Absence of mannose-binding lectin prevents hyperglycemic cardiovascular complications. The American journal of pathology. 2012. 180: 104-112. doi: 10.1016/j.ajpath.2011.09.026 PMID: 22079428
32. Man X, Zhang H, Yu H, Ma L, Du J. Increased serum mannose binding lectin levels are associated with diabetic retinopathy. Journal of diabetes and its complications. 2015; 29: 55-58. doi: 10.1016/j.jdiacomp.2014.09.013 PMID: 25457461
33. Hansen T K, Gall M A, Tarnow L, Thiel S, Stehouwer CD, Schalkwijk CG, et al. Mannose-binding lectin and mortality in type 2 diabetes. Archives of internal medicine. 2006; 166: 2007-2013. PMID: 17030835
34. Looker H C, Nyangoma S O, Cromie D, Olson JA, Leese GP, Black M, et al. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia. 2012; 55: 2335-2342. PMID: 22688348
35. Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW. Diabetic retinopathy in type 1 diabetes - a contemporary analysis of 8,784 patients. Diabetologia. 2011; 54:1977-1984. doi: 10.1007/s00125-011-2198-1 PMID: 21638132
36. Navarro J F, Mora C, Macía M, Garca J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases. 2003; 42: 53-61. PMID: 12830456
37. Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003; 26:1731-1737. PMID: 12766102
38. Nagi DK, Pettitt DJ, Bennett PH, Klein R, Knowler WC. Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM. Diabet Med. 1997; 14:449-456. PMID: 9212309
39. Zhang X, Saaddine JB, Chou CF, Cotch MF, Saaddine J, Friedman DS. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010; 304: 649-656. doi: 10.1001/jama.2010.1111 PMID: 20699456
40. Collard CD, Vakeva A, Morrissey MA, Agah A, Rollins SA, Reenstra WR, etal. Complement activation after oxidative stress:role of the lectin complement pathway. Am J Pathol. 2000; 156:1549-1556. PMID: 10793066
41. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ. Mannose binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitides serogroup B. J Infect Dis. 2001; 184:1152-1162. PMID: 11598838
42. Fortpied J, Vertommen D, Van Schaftingen E. Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes. Diabetes Metab Res Rev. 2010; 26:254-260. doi: 10.1002/dmrr.1079 PMID: 20503257